StoxInflux Healthtech Limited
NSE: INFLUX · Unclassified
Ask the data
Instant answers about Influx Healthtech Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY26 | |
|---|---|
| Revenue | 146.8 |
| EBITDA | 29.9 |
| Operating margin | 20.3% |
| Interest | 0.2 |
| Depreciation | 3.8 |
| Profit before tax | 27.2 |
| Tax | 6.7 |
| Net profit | 20.5 |
| EPS ₹ | 9.35 |
| Operating cash flow | 3.9 |
| Capex | 24.6 |
| Dividend paid | 0.0 |
| Total assets | 123.7 |
| Equity | 100.8 |
Half-yearly performance
last 3 half years · ₹ crore| H1 FY26* | H2 FY26 | H1 FY27 | |
|---|---|---|---|
| Revenue | 0.0 | 146.8 | 85.4 |
| Operating profit | 0.0 | 29.9 | 18.3 |
| Operating margin | — | 20.3% | 21.5% |
| Other income | 0.0 | 1.3 | 0.3 |
| Interest | 0.0 | 0.2 | 0.1 |
| Depreciation | 0.0 | 3.8 | 2.3 |
| Profit before tax | 0.0 | 27.2 | 16.2 |
| Tax | 0.0 | 6.7 | 4.2 |
| Net profit | 0.0 | 20.5 | 12.0 |
| EPS ₹ | 0.00 | 9.35 | 5.19 |
Returns & margins
trailing-twelve-month, per half year| H2 FY26 | H1 FY27 | |
|---|---|---|
| ROE | 20.4% | 28.9% |
| ROCE | 27.2% | 38.8% |
| Net margin | 14.0% | 14.0% |
| EBITDA margin | 20.3% | 20.8% |
| Debt / equity | 0.00 | 0.00 |
| Interest coverage | 152.28 | 136.66 |
| Asset turnover | 1.19 | 1.65 |
Balance sheet
equity vs borrowings over time · ₹ crore| MAR '26 | SEP '26 | |
|---|---|---|
| Share capital | 23.1 | 23.1 |
| Other equity / reserves | 77.6 | 89.6 |
| Total equity | 100.8 | 112.8 |
| Borrowings | 0.0 | 0.0 |
| Current liabilities | 22.7 | 27.6 |
| Non-current liabilities | 0.2 | 0.4 |
| Total assets | 123.7 | 140.8 |
| Property, plant & equipment | 27.6 | 34.3 |
| Investments | 2.3 | 5.5 |
| Inventories | 15.9 | 23.4 |
| Receivables | 33.8 | 33.9 |
| Cash & equivalents | 25.2 | 9.7 |
Cash flow
annual · ₹ crore · line = free cash flow| FY26 | |
|---|---|
| Cash from operations | 3.9 |
| Cash from investing | -25.2 |
| Cash from financing | 44.5 |
| Capex | 24.6 |
| Free cash flow | -20.7 |
| Dividends paid | 0.0 |
Where the assets sit
Sep '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Influx Healthtech Limited | 581 | 251.00 | 17.9 | 5.15 | 28.9% |
StoxGud checklist: Bullish setup · 7/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Influx Healthtech Limited?
Influx Healthtech Limited (INFLUX) closed at ₹251.00 on NSE on 06 Nov 2026.
What is the market cap of Influx Healthtech Limited?
₹581 crore at the latest close.
What is the P/E ratio of Influx Healthtech Limited?
17.9, on trailing-twelve-month earnings from its filings.
How fast is Influx Healthtech Limited growing?
Not enough filed history yet to measure Influx Healthtech Limited's growth.
How profitable is Influx Healthtech Limited?
On a trailing-twelve-month basis return on equity is 28.9%, return on capital employed 38.8%, operating margin 20.8%, net margin 14.0%.
How much debt does Influx Healthtech Limited have?
Influx Healthtech Limited is debt-free: debt to equity is 0.00 with borrowings of ₹0 cr against cash of ₹10 cr (balance sheet of 2026-09-30). Operating profit covers interest 136.7 times.
Financials parsed from Influx Healthtech Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Half-yearly from H1 FY26, annual from FY26, balance sheet from Mar '26. * = derived (full year minus the other half). This company is on NSE's SME platform and reports results half-yearly. Information only, not investment advice.